Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain-Reference-Cited by-同舟云学术

Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain

Published:2019 Issue:5 Volume:10 Page:647-659
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Banister Samuel D.¹²³⁴,Krishna Kumar Kaavya⁵²³⁴,Kumar Vineet¹²³⁴,Kobilka Brian K.⁵²³⁴,Malhotra Sanjay V.¹²³⁴^ORCID

Affiliation:

1. Department of Radiation Oncology

2. Stanford University School of Medicine

3. Stanford

4. USA

5. Department of Molecular and Cellular Physiology

Abstract

This article provides an overview of the chemotypes that have been investigated or under investigation for the development of novel neuropathic pain treatments targeting the CB₁ receptor.

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C8MD00595H

Reference157 articles.

1. Neuropathic pain: Redefinition and a grading system for clinical and research purposes

2. A new definition of neuropathic pain

3. Neuropathic pain: aetiology, symptoms, mechanisms, and management

4. The Prevalence of Neuropathic Pain: Clinical Evaluation Compared with Screening Tools in a Community Population

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1;Proceedings of the National Academy of Sciences;2024-06-03

2. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy;Biomolecules;2023-09-14

3. Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor;Frontiers in Molecular Neuroscience;2023-03-08

4. Large library docking for cannabinoid-1 receptor agonists with reduced side effects;2023-03-03

5. Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators;Life;2022-12-18